XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Statement of Cash Flows [Abstract]    
Net income (loss) $ 266 $ 597
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Interest credited to policyholders’ account balances 463 313
Policy charges and fee income (588) (650)
Net derivative (gains) losses 841 (159)
Credit and intent to sell losses on available for sale debt securities and loans 66 (10)
Investment (gains) losses, net 21 336
(Gains) losses on businesses held-for-sale 3 0
Realized and unrealized (gains) losses on trading securities (34) 92
Non-cash long-term incentive compensation expense 17 38
Amortization and depreciation 224 142
Remeasurement of liability for future policy benefits 4 22
Change in market risk benefits and purchased market risk benefits 20 (467)
Equity (income) loss from limited partnerships (21) (71)
Changes in:    
Net broker-dealer and customer related receivables/payables (641) 11
Reinsurance recoverable (456) (375)
Segregated cash and securities, net 468 (189)
Capitalization of deferred policy acquisition costs (202) (210)
Future policy benefits (95) 43
Current and deferred income taxes [1] (738) 81
Other, net (205) (152)
Net cash provided by (used in) operating activities (587) (608)
Proceeds from the sale/maturity/prepayment of:    
Fixed maturities, available-for-sale 1,481 8,651
Fixed maturities, at fair value using the fair value option 30 252
Mortgage loans on real estate 81 280
Trading account securities 162 45
Short term investments 589 6
Other 211 167
Payment for the purchase/origination of:    
Fixed maturities, available-for-sale (1,846) (9,198)
Fixed maturities, at fair value using the fair value option (41) (254)
Mortgage loans on real estate (580) (688)
Trading account securities (297) (44)
Short term investments (804) (304)
Other   569
Other (231)  
Cash settlements related to derivative instruments, net (197) 230
Investment in capitalized software, leasehold improvements and EDP equipment (18) 1
Other, net 30 116
Net cash provided by (used in) investing activities (1,430) (171)
Cash flows from financing activities:    
Deposits 4,375 3,228
Withdrawals (2,655) (2,257)
Transfers (to) from Separate Accounts 309 454
Payments of market risk benefits (172) (122)
Change in short-term financings (8) 112
Change in collateralized pledged assets (7) (40)
Change in collateralized pledged liabilities 665 545
(Decrease) increase in overdrafts payable 0 (15)
Issuance of long-term debt 496 0
Proceeds from notes issued by consolidated VIEs 0 (11)
Dividends paid on common stock (72) (70)
Dividends paid on preferred stock (14) (14)
Purchases of AB Holding Units to fund long-term incentive compensation plan awards (18) (14)
Purchase of treasury shares (214) (279)
Purchases (redemptions) of noncontrolling interests of consolidated company-sponsored investment funds 150 (56)
Distribution to noncontrolling interest of consolidated subsidiaries (89) (139)
Other, net 3 (7)
Net cash provided by (used in) financing activities 2,749 1,315
Effect of exchange rate changes on cash and cash equivalents 10 (11)
Change in cash and cash equivalents 742 525
Cash and cash equivalents, beginning of the period 4,281 5,188
Change in cash of businesses held-for-sale (5) 0
Cash and cash equivalents, end of the period 5,018 5,713
Non-cash transactions from investing and financing activities:    
Right-of-use assets obtained in exchange for lease obligations $ 10 $ 29
[1] For the period ended March 31, 2023 includes a release of $614 million deferred tax valuation allowance. Refer to Note 12 of these Consolidated Financial Statements.